These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 9181088)

  • 1. Effects of losartan on neuroleptic-induced catalepsy in mice.
    Pires JG; Silva SR; Futuro-Neto HA
    Braz J Med Biol Res; 1996 Aug; 29(8):1045-7. PubMed ID: 9181088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the 5-HT receptor antagonists cyanopindolol, ICI 169,369, cisapride and granisetron on neuroleptic-induced catalepsy in mice.
    Pires JG; Ramage AG; Silva SR; Futuro-Neto HA
    Braz J Med Biol Res; 1993 Aug; 26(8):847-52. PubMed ID: 8298521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of 5-HT3 receptor antagonists on neuroleptic-induced catalepsy in mice.
    Silva SR; Futuro-Neto HA; Pires JG
    Neuropharmacology; 1995 Jan; 34(1):97-9. PubMed ID: 7623968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-HT2 receptor blockade by ICI 170,809 does not affect the inhibitory effect of the 5-HT1A receptor ligand gepirone on neuroleptic-induced catalepsy.
    Pires JG; Silva SR; Futuro-Neto HA
    Braz J Med Biol Res; 1994 Oct; 27(10):2437-41. PubMed ID: 7640635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new class of therapeutic agents: the angiotensin II receptor antagonists.
    Timmermans PB; Smith RD
    Cardiologia; 1994 Dec; 39(12 Suppl 1):397-400. PubMed ID: 7634303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diversified pharmacology of angiotensin II-receptor blockade.
    Timmermans PB; Smith RD
    Blood Press Suppl; 1996; 2():53-61. PubMed ID: 8913541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of angiotensin AT1 receptors in the diuretic, natriuretic, kaliuretic and blood pressure responses induced by angiotensin II activation of the median preoptic nucleus in conscious rats.
    Ferreira-do-Vale C; Renzi A; Camargo GP; Saad WA; Luiz AC; Menani JV; Silveira JE; Camargo LA
    Braz J Med Biol Res; 1995 Oct; 28(10):1097-101. PubMed ID: 8634683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of motor functions involving the dopaminergic system by AT1 receptor antagonist, losartan.
    Raghavendra V; Chopra K; Kulkarni SK
    Neuropeptides; 1998 Jun; 32(3):275-80. PubMed ID: 10189063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender-related differences in the effects of nitric oxide donors on neuroleptic-induced catalepsy in mice.
    Pires JG; Costa PG; Saraiva FP; Bonikovski V; Futuro Neto HA
    Braz J Med Biol Res; 2003 Feb; 36(2):239-45. PubMed ID: 12563527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonpeptide angiotensin AT1 and AT2 receptor ligands modulate the upper limit of cerebral blood flow autoregulation in rats.
    Strömberg C; Näveri L; Saavedra JM
    J Cereb Blood Flow Metab; 1993 Mar; 13(2):298-303. PubMed ID: 8436622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of losartan, the first angiotensin II receptor antagonist.
    Timmermans PB; Duncia JV; Carini DJ; Chiu AT; Wong PC; Wexler RR; Smith RD
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S3-18. PubMed ID: 8583479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The medicine of the month. Losartan (Cozaar)].
    Scheen AJ
    Rev Med Liege; 1997 May; 52(5):367-9. PubMed ID: 9273640
    [No Abstract]   [Full Text] [Related]  

  • 13. Historical development of losartan (DuP 753) and angiotensin II receptor subtypes.
    Wong PC; Timmermans PB
    Blood Press Suppl; 1996; 3():11-4. PubMed ID: 8973760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of an angiotensin II antagonist on reperfusion arrhythmias in dogs.
    Matsuo K; Kumagai K; Annoura M; Yamanouchi Y; Handa K; Nakashima Y; Hiroki T; Arakawa K
    Pacing Clin Electrophysiol; 1997 Apr; 20(4 Pt 1):938-45. PubMed ID: 9127399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular effects after the intracerebroventricular administration of peptide and nonpeptide angiotensin antagonists in Dahl salt-sensitive rats.
    Lark LA; Wappel SM; Weyhenmeyer JA
    J Pharmacol Exp Ther; 1995 Aug; 274(2):745-51. PubMed ID: 7636738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Losartan prevents pulmonary hypertension induced by a thromboxane A2 analog].
    Bertolino F; Valentin JP; Maffre M; Jover B; Bessac AM; John GW
    Arch Mal Coeur Vaiss; 1994 Aug; 87(8):971-4. PubMed ID: 7755474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of median raphe nucleus lesions on neuroleptic-induced catalepsy and on the anticataleptic effect of buspirone.
    Pires JG; Silva SR; Ramage AG; Futuro-Neto HA
    Braz J Med Biol Res; 1993 Mar; 26(3):323-6. PubMed ID: 7903058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-hypertensive therapy by losartan. How effective is AT1 receptor blockade?
    Brunner HR
    J Hum Hypertens; 1995 Nov; 9(11):859-60. PubMed ID: 8583462
    [No Abstract]   [Full Text] [Related]  

  • 19. [Angiotensin receptor antagonist for therapy of patients with hypertension].
    Rakugi H; Ogihara T
    Nihon Rinsho; 1997 Aug; 55(8):2075-80. PubMed ID: 9284426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Losartan and the LIFE-study. Antihypertensive treatment with AT1-receptor antagonist].
    Kjeldsen SE; Omvik P
    Tidsskr Nor Laegeforen; 1996 Feb; 116(4):504-7. PubMed ID: 8644056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.